Folate deficiency is associated with oxidative stress, increased blood pressure, and insulin resistance in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 26, Issue 1, 2013, Pages 135-140

  Pravenec, Michal ^a   Kožich, Viktor ^b   Krijt, Jakub ^b   Sokolová, Jitka ^b   Zídek, Václav ^a   Landa, Vladimír ^a   Šimáková, Miroslava ^a   Mlejnek, Petr ^a   Šilhavý, Jan ^a   Oliyarnyk, Olena ^c   Kazdová, Ludmila ^c   Kurtz, Theodore W ^d  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood pressure; ectopic fat accumulation; folate deficiency; homocysteine; hypertension; oxidative stress; spontaneously hypertensive rat

Indexed keywords

ANTIOXIDANT; FOLIC ACID; HOMOCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FOLIC ACID DEFICIENCY; HEMODYNAMIC MONITORING; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY CORTEX; LIPID STORAGE; LIVER; MALE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; FOLIC ACID; FOLIC ACID DEFICIENCY; GLUCOSE INTOLERANCE; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; RATS; RATS, INBRED SHR;

EID: 84876566415     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hps015     Document Type: Article

References (40)

1. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino RB Sr, Wilson PW. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24:1403-1410. (Pubitemid 33716428)
2. Oron-Herman M, Rosenthal T, Sela BA. Hyperhomocysteinemia as a component of syndrome X. Metabolism 2003;52:1491-1495. (Pubitemid 37461120)
3. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 2007;4:143-150.
4. Pravenec M, Kurtz TW. Recent advances in genetics of the spontaneously hypertensive rat. Curr Hypertens Rep 2010;12:5-9.
5. Yen CH, Lau YT. Vascular responses in male and female hypertensive rats with hyperhomocysteinemia. Hypertension 2002;40:322-328.
6. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002;15(2 Pt 1):157-163. (Pubitemid 34161091)
7. Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC. Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessels 2000;15:135-143. (Pubitemid 32236954)
8. Vesel K, Pavlov M, Janošov B, Andl M, Zvov J, Hyanek J, Kožich V. Genetic determinants of folate status in central Bohemia. Physiol Res 2005;54:295-303. (Pubitemid 40956772)
9. Krijt J, Vackov M, Kožich V. Measurement of homocysteine and other aminothiols in plasma: advantages of using tris (2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine. Clin Chem 2001;47:1821-1828. (Pubitemid 32884218)
10. MalskH, Oliyarnyk O, HubovM, Zek V, Landa V, Šimová M, Mlejnek P, Kazdov L, Kurtz TW, Pravenec M. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis. Mol Cell Biochem 2010;335:119-125.
11. Rosolova H, Simon J, Mayer O Jr, Racek J, Dierz T, Jacobsen DW. Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res 2002;51:93-98. (Pubitemid 34266448)
12. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino RB Sr, Wilson PW;Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes Care 2001;24:1403-1410. (Pubitemid 33716428)
13. Abbasi F, Facchini F, Humphreys MH, Reaven GM. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 1999;146:175-178. (Pubitemid 29371876)
14. Fonseca V, Dicker-Brown A, Ranganathan S, Song W, Barnard RJ, Fink L, Kern PA. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 2000;49:736-741. (Pubitemid 30354580)
15. Wijekoon EP, Hall B, Ratnam S, Brosnan ME, Zeisel SH, Brosnan JT. Homocysteine metabolism in ZDF (type 2) diabetic rats. Diabetes 2005;54:3245-3251. (Pubitemid 43334381)
16. Noll C, Lacraz G, Ehses J, Coulaud J, Bailbe D, Paul JL, Portha B, Homo-Delarche F, Janel N. Early reduction of circulating homocysteine levels in Goto-Kakizaki rat, a spontaneous nonobese model of type 2 diabetes. Biochim Biophys Acta 2011;1812:699-702.
17. Buettner R, Bettermann I, Hechtl C, Gele E, Hellerbrand C, Schmerich J, Bollheimer L. Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome. Horm Metab Res 2010;42:769-774.
18. Obeid R, Hermann W. Homocysteine and lipids: A-adenosyl methionine as a key intermediate. FEBS Letters 2009;583:1215-1225.
19. MattC, Stefanello FM, Mackedanz V, Pederzolli CD, Lamers ML, Dutra-Filho CS, Dos Santos MF, Wyse AT. Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci 2009;27:337-344.
20. Sironi AM, Sicari R, Folli F, Gastaldelli A. Ectopic fat storage, insulin resistance, and hypertension. Curr Pharm Des 2011;17:3074-3080.
21. Christensen KE, Wu Q, Wang X, Deng L, Caudill MA, Rozen R. Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism. J Nutr 2010;140:1736-1741.
22. Whaley-Connell A, McCullough PA, Sowers JR. The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med 2011;12:21-29.
23. Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998;273:14085-14089. (Pubitemid 28319114)
24. Handy DE, Zhang Y, Loscalzo J: Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem 2005;280: 15518-15525. (Pubitemid 40616667)
25. Hwang SY, Siow YL, Au-Yeung KK, House J, Karmin O. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney. Am J Physiol Renal Physiol 2011;300:F189-198.
26. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, Leeson P, Neubauer S, Ratnatunga C, Pillai R, Refsum H, Channon KM. 5- methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 2006;114:1193-1201. (Pubitemid 44386484)
27. Hansrani M, Stansby G. The use of an in vivo model to study the effects of hyperhomocysteinaemia on vascular function. J Surg Res 2008;145:13-18. (Pubitemid 351221091)
28. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002;15:157-163. (Pubitemid 34161091)
29. Resstel LB, de Andrade CR, Haddad R, Eberlin MN, de Oliveira AM, Correa FM. Hyperhomocysteinaemia-induced cardiovascular changes in rats. Clin Exp Pharmacol Physiol 2008;35:949-956. (Pubitemid 351951946)
30. Hong HJ, Hsiao G, Cheng TH, Yen MH. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001;38:1044-1048. (Pubitemid 34252803)
31. Perez SC, Vianna LM. Favorable effects of pyridoxine and folic acid supplementation of shr-sp. Arch Neurocien (Mex) 2005;10:146-149. (Pubitemid 44591793)
32. KahleovR, PalyzovD, Zva K, ZvovJ, Hrach K, NovovI, Hyek J, BendlovB, Kozich V. Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. Am J Hypertens 2002;15:857-864. (Pubitemid 35168424)
33. Kalin SR, Rimm EB. Folate and vascular disease. In Bailey LB (ed), Folate in Health and Disease. 2nd edn. CRC Press: Boca Raton, FL, 2010, pp. 263-290.
34. Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) 2006;30:1197-1202. (Pubitemid 44141607)
35. Cagnacci A, Cannoletta M, Volpe A. High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. Eur J Clin Nutr 2009;63:1266-1268.
36. Frelut ML, Nicolas JP, Guilland JC, de Courcy GP. Methylenetetrahydrofolate reductase 677 C-T polymorphism: a link between birth weight and insulin resistance in obese adolescents Int J Pediatr Obes 2011;6:e312-317.
37. Stewart CP, Christian P, Schulze KJ, Leclerq SC, West KP Jr, Khatry SK. Antenatal micronutrient supplementation reduces metabolic syndrome in 6-to 8-year-old children in rural Nepal. J Nutr 2009;139:1575-1581.
38. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454. (Pubitemid 29220543)
39. Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PW, Rosenberg IH, Selhub J. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr 2001;131:3277-3280. (Pubitemid 33136149)
40. Yeung L, Yang Q, Berry RJ. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA 2008;300:2486-2487.